Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
You can purchase shares of Sage Therapeutics (NASDAQ:SAGE) through any online brokerage.
Other companies in Sage Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR) and Altimmune (NASDAQ:ALT).
Sage Therapeutics has a consensus price target of $24.36.
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $6.9687 last updated September 25, 2024 at 7:53 PM EDT.
There are no upcoming dividends for Sage Therapeutics.
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Sage Therapeutics.
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.